Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Topical Morphine for Painful Neoplastic Wounds
NCT05800834Phase 2Unknown
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- Sep 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of morphine hydrochloride in cancer pain, sponsored by Instituto Nacional de Câncer José Alencar Gomes da Silva. Status: unknown.
02
Drugs
morphine hydrochloride
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT05800834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05800834.